Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Marina Cuchel*, Eric Bruckert, Henry N. Ginsberg, Frederick J. Raal, Raul D. Santos, Robert A. Hegele, Jan Albert Kuivenhoven, Børge G. Nordestgaard,
Olivier S. Descamps, Elisabeth Steinhagen-Thiessen, Anne Tybjærg-Hansen,
Gerald F. Watts, Maurizio Averna, Catherine Boileau, Jan Bore ́ n, Alberico L. Catapano, Joep C. Defesche, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, Luis Masana, Pa ̈ ivi Pajukanta, Klaus G. Parhofer, Kausik K. Ray, Anton F. H. Stalenhoef, Erik Stroes, Marja-Riitta Taskinen, Albert Wiegman, Olov Wiklund, and M. John Chapman
Acanthosis nigricans in type 2 diabetes: prevalence, correlates and potential as a simple clinical screening tool - a cross-sectional study in the Caribbean
Sarasvati Bahadursingh*, Catherine Mungalsingh, Terence Seemungal and Surujpal Teelucksingh
Characteristics and effectiveness of diabetes self-management educational programs targeted to racial/ethnic minority groups: a systematic review, meta-analysis and meta-regression
Ignacio Ricci-Cabello1,2*, Isabel Ruiz-Pérez2,3, Antonio Rojas-García2,3, Guadalupe Pastor3, Miguel Rodríguez-Barranco3 and Daniela C Gonçalves1
Study protocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial
Yvonne HM Krul-Poel1, Hans van Wijland2, Frank Stam1, Edwin ten Boekel3, Paul Lips4 and Suat Simsek
Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial
Nicole J Kellow1*, Melinda T Coughlan2,3, Gayle S Savige1 and Christopher M Reid1
